Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy.

Cornblath, David R; van Doorn, Pieter A; Hartung, Hans-Peter; Merkies, Ingemar S J; Katzberg, Hans D; Hinterberger, Doris; Clodi, Elisabeth

Cornblath, David R; van Doorn, Pieter A; Hartung, Hans-Peter; Merkies, Ingemar S J; Katzberg, Hans D; Hinterberger, Doris; Clodi, Elisabeth.

Afiliação

Cornblath DR; Department of Neurology, Johns Hopkins University, Baltimore, MD 21287, USA.
van Doorn PA; Department of Neurology, Erasmus University Medical Center, Rotterdam 3015CE, The Netherlands.
Hartung HP; Department of Neurology, Heinrich Heine University, Düsseldorf 40225, Germany.
Merkies ISJ; Brain and Mind Center, University of Sydney, Sydney, NSW 2050, Australia.
Katzberg HD; Department of Neurology, Medical University of Vienna, Vienna 1090, Austria.
Hinterberger D; Department of Neurology, Palacky University, Olomouc 771 47, Czech Republic.
Clodi E; Department of Neurology, Maastricht University Medical Center, Maastricht 6229 HX, The Netherlands.

Brain ; 145(3): 887-896, 2022 04 29.

Article em En | MEDLINE | ID: mdl-35038723

Assuntos

Polirradiculoneuropatia Desmielinizante Inflamatória Crônica; Método Duplo-Cego; Humanos; Imunoglobulinas Intravenosas/uso terapêutico; Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/tratamento farmacológico; Estudos Prospectivos; Resultado do Tratamento

Palavras-chave

Panzyga®; ProCID study; chronic inflammatory demyelinating polyneuropathy; intravenous immunoglobulin; randomized controlled trial

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polirradiculoneuropatia Desmielinizante Inflamatória Crônica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google